Sharon Bio-Medicine Profile
Key Indicators
- Authorised Capital ₹ 35.00 Cr
as on 15-05-2024
- Paid Up Capital ₹ 1.15 Cr
as on 15-05-2024
- Company Age 35 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 2,595.42 Cr
as on 15-05-2024
- Revenue -69.47%
(FY 2016)
- Profit -32.47%
(FY 2016)
- Ebitda -289.26%
(FY 2016)
- Net Worth -287.06%
(FY 2016)
- Total Assets -28.54%
(FY 2016)
About Sharon Bio-Medicine
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 532908.
The Corporate was formerly known as Sharon Synthochem Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 35.00 Cr and a paid-up capital of Rs 1.15 Cr.
The company has closed loans amounting to ₹2,595.42 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sharon Bio-Medicine Limited India are Lalit Misra as CFO and Rakhi Makhloga as Company Secretary. Jayant Rao, Purushottam Sharma, and Mukeshkumar Singh serve as directors at the Company.
- CIN/LLPIN
L24110MH1989PLC052251
- Company No.
052251
- Stock Symbol
BSE : 532908
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
19 Jun 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Raigarh, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sharon Bio-Medicine?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lalit Misra  | CFO | 23-May-2015 | Current |
| Rakhi Makhloga | Company Secretary | 23-Jan-2023 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jayant Rao | Director | 17-Jun-2023 | Current |
| Purushottam Sharma | Director | 17-Jun-2023 | Current |
| Mukeshkumar Singh | Whole-Time Director | 17-Jun-2023 | Current |
Financial Performance and Corporate Structure Insights of Sharon Bio-Medicine.
Sharon Bio-Medicine Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 69.47% decrease. The company also saw a substantial fall in profitability, with a 32.47% decrease in profit. The company's net worth observed a substantial decline by a decrease of 287.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sharon Bio-Medicine?
In 2016, Sharon Bio-Medicine had a promoter holding of 52.26% and a public holding of 47.74%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 09 Sep 2015 | ₹137.49 Cr | Satisfied |
Sbicap Trustee Company Limited Creation Date: 30 Mar 2015 | ₹683.14 Cr | Satisfied |
Canara Bank Creation Date: 29 Dec 2014 | ₹9.00 Cr | Satisfied |
How Many Employees Work at Sharon Bio-Medicine?
Sharon Bio-Medicine has a workforce of 258 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sharon Bio-Medicine, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sharon Bio-Medicine's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
